These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8084119)
1. [Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina]. Kaliakin IE; Mit'kin AF Kardiologiia; 1993; 33(2):15-7. PubMed ID: 8084119 [TBL] [Abstract][Full Text] [Related]
2. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit]. Volkov VS; Bratoliubov VP Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730 [TBL] [Abstract][Full Text] [Related]
3. [Constant-frequency trans-esophageal electric atrial stimulation for evaluation of the severity of illness in patients with stenocardia and the anti-angina effect of erinit]. Gasilin VS; Sidorenko BA; Lazarev IA; Smirnov MIu Kardiologiia; 1990 Dec; 30(12):27-30. PubMed ID: 2097391 [TBL] [Abstract][Full Text] [Related]
4. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity. Amsterdam EA; Lee G; Awan NA; Low R; Mason DT Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533 [TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline]. Volkov VS; Bratoliubov VP Sov Med; 1985; (7):77-80. PubMed ID: 3934766 [No Abstract] [Full Text] [Related]
6. [The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia]. Zakirova AN; Mingazetdinova LN; Kamilov FKh; Lankin VZ; Lebedev AV; Konovalova GG Ter Arkh; 1994; 66(9):24-8. PubMed ID: 7992206 [TBL] [Abstract][Full Text] [Related]
7. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome. Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J; J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970 [TBL] [Abstract][Full Text] [Related]
8. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)]. Matzkies F; Berg G Dtsch Med Wochenschr; 1974 Nov; 99(48):2464-5. PubMed ID: 4448143 [No Abstract] [Full Text] [Related]
9. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin. Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956 [No Abstract] [Full Text] [Related]
10. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris. Cole RE; Goldberg RI Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503 [No Abstract] [Full Text] [Related]
11. High-dose allopurinol in patients with stable angina pectoris. Liang Y; Wang S Lancet; 2010 Oct; 376(9749):1299; author reply 1299-300. PubMed ID: 20951887 [No Abstract] [Full Text] [Related]
12. [Effect of carvedilol on lipid peroxidation in patients with stable angina]. Kowalski J; Błaszczyk J; Kowalski M; Cegliński T; Wróbel W; Irzmański R; Krzemińska A; Pawlicki L Pol Merkur Lekarski; 2005 Feb; 18(104):156-9. PubMed ID: 17877120 [TBL] [Abstract][Full Text] [Related]
14. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD]. Zakirova AN Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610 [TBL] [Abstract][Full Text] [Related]
15. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients]. Dunaev VV; Kraĭdashenko OV; Berezin AE Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris]. Kośmicki MA; Malczewska B; Sadowski Z Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. Rajendra NS; Ireland S; George J; Belch JJ; Lang CC; Struthers AD J Am Coll Cardiol; 2011 Aug; 58(8):820-8. PubMed ID: 21835317 [TBL] [Abstract][Full Text] [Related]
18. High-dose allopurinol in patients with stable angina pectoris. Kim T; Kim J; Oh J; Kang SM; Lee MG Lancet; 2010 Oct; 376(9749):1298; author reply 1299-300. PubMed ID: 20951883 [No Abstract] [Full Text] [Related]
19. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate. Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736 [No Abstract] [Full Text] [Related]
20. Allopurinol as a cardiovascular drug. Kelkar A; Kuo A; Frishman WH Cardiol Rev; 2011; 19(6):265-71. PubMed ID: 21983313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]